Lieven Gevaert Measurement of Neurodegenerative Biomarkers in Blood Gentaur has developed prototype assays capable of measuring the oligomeric and aggregated forms (if present) of ß-amyloid, α-synuclein, and phospho-tau in blood. The assays have been tested on blood s... Jul 21, 2025
Lieven Gevaert Novel Aggregated Biomarker Assay Technology The challenge in developing blood tests for these aggregated proteins is to achieve the required level of sensitivity (lowest practical detection limit) and appropriate specificity for the oligomeric ... Jul 21, 2025
Lieven Gevaert Neurodegenerative Disorder – A Problem Caused by Protein Aggregation In the field of neurodegeneration, there is a particular need to detect biomarkers in blood that are indicative of the early onset and development of these conditions. Currently, the early stages of t... Jul 21, 2025
